Elicera Therapeutics
Elicera Therapeutics will participate in upcoming industry and investor conferences during the fall
ISCT Europe 2024 Regional Meeting, September 4
Elicera Therapeutics will participate in the annual conference organized by the scientific network International Society for Gene & Cell Therapy. For more information: https://www.isctglobal.org/iscteu2024/home
CICON24 (Eighth International Cancer Immunotherapy Conference), September 8
Elicera Therapeutics' co-founder and CSO, Magnus Essand, has been invited to present iTANK and the company's development of CAR T-cell therapies. For more information: www.cancerimmunotherapyconference.org
Biostock Investor Meeting, September 12
Elicera Therapeutics' CEO, Jamal El-Mosleh, will present the company at an investor meeting organized by Biostock. For more information: https://www.biostock.se/investing-in-life-science/
NLSDays 2024, September 18-19
Elicera Therapeutics will participate in Nordic Life Science Days, the Nordic region's largest business conference in life science. For more information: www.nlsdays.com/about-the-event
Miltenyi Cell and Gene Therapy Summit 2024, October 8
Elicera Therapeutics' co-founder and CSO, Magnus Essand, has been invited to present iTANK and the company's development of CAR T-cell therapies. For more information: www.miltenyibiotec.com/UN-en/about-us/conferences-and-events/miltenyi-biotec-s-cell-and-gene-therapy-days.html
BIO-EUROPE, November 4
Elicera Therapeutics will participate in Europe's largest business conference in life science. For more information: www.informaconnect.com/bioeurope
Biostock Summit, November 19
Elicera Therapeutics will present at the annual investor meeting organized by Biostock. The company's presentation will be published on their website.
Datum | 2024-09-03, kl 08:45 |
Källa | Cision |